Shares of Hims & Hers Health (NYSE: HIMS) sank 10.5% this week, according to data from S&P Global Market Intelligence. The ...

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...

ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs ...

CAG has also flagged previous AAP govt's abject failure to meet the target of establishing 1,000 Mohalla Clinics by 2017, it ...

Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's ...

A federal court rejected Novartis' legal challenge to the Medicare Drug Price Negotiation Program, ruling that it does not ...

Metsera Inc (NASDAQ: MTSR) has been pushing to the upside since its debut on Nasdaq on January 31st. But analysts are ...

JP Morgan upgrades Amneal Pharmaceuticals, citing strong Crexont sales, robust generics growth, and a higher 2025 revenue ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the ...

Company has A M Ghelani & Co. as its auditors. As on 31-12-2024, the company has a total of 1.61 Crore shares outstanding.Kilitch Drug Share Price Today is Rs. 317.90. On previous day, the Kilitch ...